Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07868926
PHASE1
Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 After a Single Oral Dose
Sponsor: Vertex Pharmaceuticals Incorporated
View on ClinicalTrials.gov
Summary
The purpose of the study is to evaluate the pharmacokinetics, safety and tolerability of VX-407 following a single oral dose.
Official title: A Phase 1, Open-Label, Mass Balance Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-VX-407 Following Single Oral Administration in Healthy Subjects
Key Details
Gender
MALE
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2026-10-19
Completion Date
2026-12-15
Last Updated
2026-10-09
Healthy Volunteers
Yes
Interventions
DRUG
14C-VX-407
Solution for Oral Administration.